Patients are asking if they should stop Vytorin

Patients are asking if they should stop Vytorin...due to all the press that it doesn't work any better than simvastatin alone.

Preliminary results of the "ENHANCE" trial SUGGEST that Vytorin (ezetimibe/simvastatin) does not work better than simvastatin alone for slowing atherosclerosis.

This is a big surprise and is causing many experts to scramble for an explanation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote